MAXHEALTH - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.3
Show all parameters (20 more)
🧾 Trade Setup
Optimal buy price: 1045 ₹. Initial stop-loss: 1030 ₹. Target profit level 1: 1065 ₹, based on potential momentum continuation. Target profit level 2: 1080 ₹ if volume confirms initial breakout, but be prepared to exit quickly given the high valuation. Overall, this is a risky trade due to overvaluation; prioritize capital preservation with tight stop-loss orders.
✅ Positive
High volume today (22M shares) suggests strong interest. The recent price increase of 2% is a positive signal and could continue if momentum holds.
⚠️ Limitation
The extremely high P/E ratio of 140 compared to the industry average of 49.9 indicates significant overvaluation, presenting a substantial risk of a correction if volume diminishes or negative news emerges. Additionally, the declining FII holding (-3.61%) could signal reduced confidence from institutional investors.
🏭 Industry
The healthcare sector is currently experiencing moderate volatility driven by regulatory changes and evolving patient demographics, however, MAXHEALTH's recent price increase aligns with a broader upward trend within the hospital services industry.